Salivary gland scintigraphy with 99mTc-pertechnetate

Author(s):  
H. P. Van den Akker ◽  
E. Busemann-Sokole
1986 ◽  
Vol 32 (8) ◽  
pp. 1342-1351
Author(s):  
Tsuyoshi HATA ◽  
Masaru HOSODA ◽  
Michio FUKUDA ◽  
Natsuki SEGAMI ◽  
Sumihisa KOWAKA

Open Medicine ◽  
2010 ◽  
Vol 5 (2) ◽  
pp. 246-250
Author(s):  
Ozgur Yoruk ◽  
Bedri Seven ◽  
Erhan Varoglu ◽  
Harun Ucuncu ◽  
Ali Sahin ◽  
...  

AbstractThe purpose of this study was to compare the quantitative parameters of salivary gland functions in patients with allergic rhinitis and healthy volunteers using [99mTc] pertechnetate salivary gland scintigraphy. Thirty-six patients with allergic rhinitis (14 males and 22 females, mean age 30.6 ± 5.2 years) and thirty-nine healthy controls (18 males and 21 females, mean age 32.2 ± 5.6 years) were evaluated. Dynamic salivary gland scintigraphy was performed after intravenous administration of 185 MBq (5 mCi) of [99mTc] pertechnetate for 25 minutes. Lemon juice was used to stimulate the salivary glands. On the basis of the time-activity curves, the following glandular function parameters were calculated for the parotid and submandibular salivary glands: uptake ratio, maximum accumulation, and ejection fraction. Statistically, all the functional parameters of the parotid and submandibular glands obtained for the allergic rhinitis patients were significantly lower than those of the healthy controls group (p < 0.05). This study demonstrated that there was a significant difference in salivary gland function between patients with allergic rhinitis and healthy controls, which can easily be evaluated by [99mTc] pertechnetate salivary gland scintigraphy.


2013 ◽  
Vol 106 ◽  
pp. S350-S351
Author(s):  
L. Tuomikoski ◽  
J. Collan ◽  
M. Kapanen ◽  
J. Keyriläinen ◽  
K. Saarilahti ◽  
...  

Author(s):  
Tomohiro Itonaga ◽  
Koichi Tokuuye ◽  
Ryuji Mikami ◽  
Akira Shimizu ◽  
Hiroki Sato ◽  
...  

Objective: Xerostomia is the most common treatment-related toxicity after radiotherapy (RT) for head and neck carcinoma, reducing the quality of life of patients due to a decrease in salivary gland function. Methods: Salivary gland scintigraphy was performed to quantitatively evaluate the salivary gland functions in patients undergoing RT. It was done chronologically for 62 salivary glands of 31 patients before RT and retested 12 months later. Results: The salivary gland functions of most patients deteriorated post-RT and recovered when the radiation dose to the salivary gland was not high. The mean dose to the salivary gland was found to be the most reliable factor in deteriorating salivary gland function, and the tolerance dose was determined to be 46 Gy. The recovery rate of salivary gland function after 1 year of RT was 72% in the RT alone group (n = 10), 56% in the conformal radiotherapy group (n = 15), and 44% in the bioradiotherapy group (n = 6). Conclusion: Scintigraphy revealed that the salivary glands recovered from post-RT hypofunction when decreased doses were administered. The determined tolerance dose of 46 Gy may guide the approach to minimizing associated xerostomia in RT. Advances in knowledge: In this study, the average tolerated dose to the salivary glands was 46 Gy.


2013 ◽  
pp. 123-131
Author(s):  
Karen Ramer ◽  
Eleanor Mantel ◽  
Janet S. Reddin ◽  
Gang Cheng ◽  
Abass Alavi

Sign in / Sign up

Export Citation Format

Share Document